Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 4 I, 2000, Pages 1247-1251

  Paredi, Paolo ^b   Kharitonov, Sergei A ^b   Leak, David ^b   Shah, Pallav L ^b   Cramer, Derek ^b   Hodson, Margaret E ^b   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; ETHANE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTAMINATION; CYSTIC FIBROSIS; DRUG EFFECT; EXHALATION; FEMALE; HUMAN; INFLAMMATORY CELL; LIPID PEROXIDATION; LUNG LAVAGE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TOTAL LUNG CAPACITY;

EID: 0034012328     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.4.9906122     Document Type: Article

References (35)

1. Brown, R. K., and F. J. Kelly. 1994. Evidence of increased oxidative damage in patients with cystic fibrosis. Pediatr. Res. 36:487-493.
2. Brown, R. K., and F. J. Kelly. 1994. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49:738-742.
3. Portal, B. C., M.-J. Richard, H. S. Faure, A. J. Hadjian, and A. E. Favier. 1995. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am. J. Nutr. 61:843-847.
4. Witko-Sarsat, V., C. Delacourt, D. Rabier, J. Bardet, A. T. Nguyen, and B. Descamps-Latscha. 1995. Neutrophil-derived long lived oxidants in cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 152:1910-1916.
5. Brown, R. K., H. Wyatt, J. F. Price, and F. J. Kelly. 1996. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur. Respir. J. 9:334-339.
6. Hull, J., P. Vervaart, K. Grimwood, and P. Phelan. 1997. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52:557-558.
7. Pryor, W. A., and J. P. Stanley. 1975. A suggested mechanism for the production of malondialdehyde during the autoxidation of polyunsaturated fatty acids: nonenzymatic production of prostaglandin endoperoxides during autoxidation. J. Org. Chem. 40:3616-3618.
8. Kneepkens, C. M. F., G. Lepage, and C. C. Roy. 1994. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17:127-160.
9. Hoshino, E., R. Shariff, and A. Van Gossum. 1990. Vitamin E suppresses increased lipid peroxidation in cigarette smokers. J. Parent. Nutr. 14: 300-305.
10. Habib, M. P., N. C. Clements, and H. S. Garewal. 1995. Cigarette smoking and ethane exhalation in humans. Am. J. Respir. Crit. Care Med. 151:1368-1372.
11. Kazuy, M., K. A. Andreoni, E. J. Norris, A. S. Klein, J. F. Burdick, C. Beattie, S. S. Sehnert, R. W. Bell, G. B. Bulkley, and T. H. Risby. 1999. Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. Free Radic. Biol. Med. 13:509-515.
12. Zarling, E. J., and M. Clapper. 1987. Technique for gas-chromatographic measurement of volatile alkanes from single breath samples. Clin. Chem. 33:140-141.
13. Aulik, I. V. 1966. Gas chromatographic analysis of exhaled air and acetylene mixture. Biull. Eksp. Biol. Med. 62:115-117.
14. Kharitonov, S. A., D. H. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
15. Kharitonov, S. A., A. U. Wells, B. J. O'Connor, P. J. Cole, D. M. Hansell, R. B. Logan-Sinclair, and P. J. Barnes. 1995. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 151: 1889-1893.
16. Keyse, S. M., L. A. Applegate, Y. Tromvoukis, and R. M. Tyrrel. 1990. Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol. Cell. Biol. 10:4967-4969.
17. Horvath I., L. E. Donelly, P. Paredi, S. A. Kharitonov, and P. J. Barnes. 1998. Elevated levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of chronic inflammation. Thorax 53:668-672.
18. Paredi, P., P. Montuschi, P. L. Shaha, P. Sullivan, M. E. Hodson, S. A. Kharitonov, and P. J. Barnes. 1998. Exhaled carbon monoxide is elevated in cystic fibrosis: a new test for disease monitoring? Eur. Respir. J. 12:235S.
19. Paredi, P., S. Loukides, S. Ward, D. Cramer, M. Spicer, S. A. Kharitonov, and P. J. Barnes. 1998. Exhaled flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis. Thorax 53:775-779.
20. Kharitonov, S. A., K. Alving, and P. J. Barnes. 1997. Exhaled and nasal nitric oxide measurements: recommendations. Eur. Respir. J. 7:1683-1693.
21. Rosenthal, M., S. H. Bain, D. Cramer, P. Helms, D. Denison, A. Bush, and J. O. Warner. 1993. Lung function in white children aged 4 to 19 years: I - Spirometry. Thorax 48:794-802.
22. Quanjer, P. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J. C. Yernault. 1993. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl. 16:5-40.
23. Worlitzsch, D., G. Herberth, M. Ulrich, and G. Doring. 1998. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur. Respir. J. 11:377-383.
24. Barnes, P. J. 1990. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 9:235-243.
25. Paredi, P., M. J. Leckie, I. Horvath, L. Allegra, S. A. Kharitonov, and P. J. Barnes. 1999. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge. Eur. Respir. J. 13:48-52.
26. Otterbein, L., S. L. Sylvester, and A. Choi. 1995. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 13:595-601.
27. Applegate, L. A., P. Luscher, and R. M. Tyrrel. 1991. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:974-978.
28. Wilmott, R. W., J. T. Kassab, P. L. Kilian, W. R. Benjamin, S. D. Douglas, and R. E. Wood. 1990. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 142:365-368.
29. Kelley, T. J., and M. L. Drumm. 1998. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 102:1200-1207.
30. Grasemann, H., I. Ioannidis, R. P. Tomkiewicz, H. de Groot, B. K. Rubin, and F. Ratjen. 1998. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 78:49-53.
31. Jones, K. L., T. W. Bryan, P. A. Jinkins, K. L. Simpson, M. B. Grisham, M. W. Owens, S. A. Milligan, B. A. Markewitz, and R. A. Robbins. 1998. Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am. J. Physiol. 275:L1120-L1126.
32. Habib, M. P., L. J. Tank, L. C. Lane, and H. S. Garewald. 1999. Effect of vitamin E on exhaled ethane in cigarette smokers. Chest 115:684-690.
33. Marumo, T., V. B. Schini-Kerth, R. P. Brandes, and R. Busse. 1998. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension 32:1083-1088.
34. Inoue, H., H. Aizawa, S. Fukuyama, S. Takata, K. Matsumoto, M. Shigyo, H. Koto, and N. Hara. 1999. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung 177:53-62.
35. Bryant, C. E., M. Perretti, and R. J. Flower. 1998. Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo: a possible role for lipocortin 1. Biochem. Pharmacol. 55:279-285.